[Experimental Studies of VEGF-C Gene for the Treatment of Chronic Obstructive Lymphedema in Mouse Tail Model].

Xue-Qing Hu,Zhao-Hua Jiang,Ning-Fei Liu
DOI: https://doi.org/10.3760/j.issn:1009-4598.2008.03.012
2008-01-01
Abstract:OBJECTIVE:To study the therapeutic effect of vascular endothelial growth factor C (VEGF-C) gene for chronic obstructive lymphedema in mouse tail model which may provide a new treatment for lymphedema.METHODS:RT-PCR and immunoabsorption were applied to detect VEGF-C gene expression in fibroblasts and secretion of VEGF-C protein in COS7 cells respectively after pCDNA3.1 (+) VEGF-C transfection. A mouse tail model of chronic obstructive lymphedema was created. Then the pcDNA3.1-VEGF-C plasmid was injected into the tail. The effect of modulating lymphangiogenesis was observed.RESULTS:Compared with control group, overexpression of VEGF-C enhanced lymphangiogenesis in vivo and mouse tail skin suffering chronic obstructive lymphedema was improved by VEGF-C gene significantly.CONCLUSIONS:VEGF-C can improve the lymphedema through enhancing lymphangiogenesis.
What problem does this paper attempt to address?